期刊全稱 | Beta-Blockers in the Elderly | 影響因子2023 | Erich Lang,Fritz S?rgel,Lothar Blaha | 視頻video | http://file.papertrans.cn/185/184352/184352.mp4 | 圖書封面 |  | 影響因子 | In conjunction with the Twelfth International Congress of Gerontology, the Carl-Korth Institute for Cardiovascular Research organized an international symposium on "Beta- Blockers in the Elderly." It was the intention of the Scientific Committee that during this symposium we would discuss the specific problems and therapeutic implications arising when elderly people have to be treated with beta-blocking agents. Special emphasis was placed on the side effects and the age- dependent features of beta-blocker therapy. Beta-blockers have become established in the treatment of both cardiovascular diseases and neuropsychiatric disorders. Their effectiveness in patients suffering from coronary heart disease, hypertension, and hyperkinetic cardiac syndromes has long been proven. The development of new, selectively active beta-blockers has substantially reduced the number of possible side effects, thus enhancing therapeutic safety. Because side effects cannot be eliminated, however, beta- blockers have been introduced only hesitantly into treatment of the elderly. This book is the first wide-ranging survey of the use of beta- blockers in elderly patients. The articles contained herei- writte | Pindex | Conference proceedings 1982 |
The information of publication is updating
|
|